Cargando…
Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study
It is becoming increasingly evident that genetic variants contribute to the development of opioid addiction. An elucidation of these genetic factors is crucial for a better understanding of this chronic disease and may help to develop novel therapeutic strategies. In recent years, several candidate...
Autores principales: | Beer, Beate, Erb, Robert, Pavlic, Marion, Ulmer, Hanno, Giacomuzzi, Salvatore, Riemer, Yvonne, Oberacher, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783401/ https://www.ncbi.nlm.nih.gov/pubmed/24086514 http://dx.doi.org/10.1371/journal.pone.0075359 |
Ejemplares similares
-
Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways
por: Wu, Bohua, et al.
Publicado: (2021) -
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics
por: Barratt, Daniel T, et al.
Publicado: (2012) -
Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects
por: Rhodin, Annica, et al.
Publicado: (2013) -
Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females
por: Clarke, Toni-Kim, et al.
Publicado: (2013) -
Elevated OPRD1 promoter methylation in Alzheimer’s disease patients
por: Ji, Huihui, et al.
Publicado: (2017)